Home » Topics » Regulatory

Regulatory
RSS

Apotex launches generic ranitidine in U.S.

Sep. 16, 1997

Topical foscarnet for treatment of herpes labialis

Sep. 11, 1997

Tolmetin eyedrop formulation evaluated in rabbits

Sep. 9, 1997

Pharmacia & Upjohn's urinary incontinence treatment approved in Sweden

Sep. 9, 1997

RTP licenses improved propofol formulation to AMRAD

Sep. 5, 1997

Novartis migraine treatment nears U.S. approval

Sep. 5, 1997

Merck's asthma treatment receives first approvals

Sep. 4, 1997

First approval for Zeneca's Seroquel

Sep. 3, 1997

Ranitidine shows no benefit in psoriasis

Sep. 2, 1997

Migraine prophylaxis with bisoprolol

Sep. 1, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...